首页> 外文期刊>The Chinese-German Journal of Clinical Oncology >Expression of Survivin Gene and Its Relationship with Clinical Multidrug Resistance in Osteosarcoma
【24h】

Expression of Survivin Gene and Its Relationship with Clinical Multidrug Resistance in Osteosarcoma

机译:Survivin基因在骨肉瘤中的表达及其与临床多药耐药的关系

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: To study the expression of survivin and its relationship with clinical multidrug resistance in osteosarcoma. Methods: By using immunohistochemistry (S-P) method, the expression of Survivin in osteosarcoma, osteochondroma and normal osseous tissue, and the expression of P-glycoprotein in osteosarcoma was detected. Results: Survivin positive expression rate was 65.71% in osteosarcoma, but no expression of Survivin was detectable in osteochondroma and normal osseous tissue. The positive expression rate of Survivin was significantly associated with Enneking clinical stages and histological typing (WHO), but no relationship was found among Survivin expression and age, sex and tumor location. The positive expression rate of P-glycoprotein was 45.71%. There was a significant correlation between Survivin and p-glycoprotein. Conclusion: Survivin overexpression was significantly associated with clinical multidrug resistance in osteosarcoma. It could be a potential target for treatment of osteosarcoma.
机译:目的:探讨survivin在骨肉瘤中的表达及其与临床多药耐药的关系。方法:采用免疫组织化学(S-P)法检测survivin在骨肉瘤,骨软骨瘤和正常骨组织中的表达,并检测P-糖蛋白在骨肉瘤中的表达。结果:骨肉瘤中Survivin阳性表达率为65.71%,而在骨软骨瘤和正常骨组织中均未检测到Survivin表达。 Survivin的阳性表达率与Enneking临床分期和组织学分型(WHO)显着相关,但是Survivin的表达与年龄,性别和肿瘤位置之间没有相关性。 P-糖蛋白的阳性表达率为45.71%。 Survivin与p-糖蛋白之间存在显着相关性。结论:Survivin过表达与骨肉瘤临床多药耐药性显着相关。它可能是治疗骨肉瘤的潜在靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号